Director/PDMR Shareholding

RNS Number : 2255W

N4 Pharma PLC

10 November 2017

 

10^th November 2017

N4 Pharma plc (the "Company")

Notification of Transaction by Directors/PDMRs

The Company was notified on 10^th November 2017 that a Person Discharging Management Responsibilities ("PDMR"), had purchased shares in the Company as set out below. Following this purchase, Nigel Theobald now has a total beneficial interest in 12,255,233 Ordinary Shares, representing 16.4% of the issued share capital of the Company.

The Company's share capital consists of 74,714,285 Ordinary Shares with voting rights.

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Nigel Theobald
2	Reason for the notification
a)	Position/status	CEO and Director
b)	Initial notification/ Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	N4 Pharma Plc
b)	LEI	213800I841D2RKMFK955
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Oridinary shares BGP 0.0004 ISIN code GB00BYW8QM32
b)	Nature of the transaction	Direct purchase of shares
c)	Price(s) and volume(s)	Price	volume
		£0.07925	56,656
d)	Aggregated information - Aggregated price - Aggregated volume - Aggregated total	n/a
e)	Date of the transaction	10th November 2017
f)	Place of the transaction	London Stock Exchange, AIM
g)	Additional Information

 

END

 

 

DSHEAKFEFEDXFFF